Previous 10 | Next 10 |
home / stock / lsl:cc / lsl:cc news
FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase. Gross margins for FY-2023 up $3.8 million compared to FY-2022 Net loss for FY-2023 of $8.5 million compared to $8.1 million for FY-2022 Q4-2023 Revenues of $3.5 million, u...
BOUCHERVILLE, Quebec, April 24, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the second and final tranche of its private placement financing of Units (as defined herea...
BOUCHERVILLE, Quebec, April 23, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Company " or " LSL Pharma" ), a Canadian integrated pharmaceutical company, today announced the appointment of Diane Beaudry and Mario Paradis to its Board of Directors. "It is my ...
BOUCHERVILLE, Québec, April 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the upsizing of its previously communicated non-brokered private placement fi...
BOUCHERVILLE, Quebec, , April 09, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC (TSXV: LSL) (the " Company " or " LSL Pharma "), a Canadian integrated pharmaceutical company, announced today that it will participate in the Bloom Burton & Co. Healthcare Investor Conference. Mr. Rob...
$2.7M cash investments secured including $0.4M from Insiders $3.75M of Debt converted BOUCHERVILLE, Quebec, March 19, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical com...
Up to $3.5 M in cash proceeds Up to $4.5 M in debts conversion Proceeds to be used to further expand production capacity BOUCHERVILLE, Québec, March 07, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma ...
BOUCHERVILLE, Québec, Jan. 08, 2024 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “ Company ” or “ LSL Pharma Group ”), a Canadian integrated pharmaceutical company, announces that it extends until February 7, 2024 its brokered privat...
BOUCHERVILLE, Québec, Dec. 08, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “ Company ” or “ LSL Pharma Group ”), a Canadian integrated pharmaceutical company, is pleased to announce that the Company has closed the second tranch...
BOUCHERVILLE, Quebec, Dec. 04, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC (TSXV: LSL) ("the Company" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce the appointment of Mr. Luc Mainville as Senior Vice President and Chief Financial Officer effective Decem...
News, Short Squeeze, Breakout and More Instantly...
Bunker Hill Mining Corp. Company Name:
LSL:CC Stock Symbol:
CNQC Market:
BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered priva...
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholder...
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has met the closing conditions of a non-brokered private placement for $1,5 million represent...